Funding for this research was provided by:
This work was supported by GRAIL Bio UK Ltd through a contract with King's College London/Queen Mary University of London.
This work was supported by GRAIL Bio UK Ltd through a contract with King's College London/Queen Mary University of London.
This work was supported by GRAIL Bio UK Ltd through a contract with King's College London/Queen Mary University of London.
Article History
Received: 8 April 2024
Revised: 5 August 2024
Accepted: 7 August 2024
First Online: 27 August 2024
Competing interests
: JW reports research income from GRAIL Bio UK Ltd, which funds 20% of her salary and the full salaries of LAVM and NSB through a contract with King’s College London/Queen Mary University of London.
: Ethics approval was granted by King’s College London, June 2023 (LRM-22/23-36139). Consent was assessed with a single question presented to participants after they had read the information page. This study was performed in accordance with the Declaration of Helsinki.